2025 Agenda
Monday, October 13
Time
Event
8:00 am – Lobby Level
Registration Opens
9:45 am – 2nd Floor
Welcome Remarks
-
Sara Jane Demy, Founder & CEO, Demy-Colton
10:00 am – 2nd Floor
“Big Think" Fireside Chat
Biopharma: What the Future Looks Like
-
James Flynn, Managing Partner, Deerfield
Interviewed by:
-
Sara Jane Demy, Founder & CEO, Demy-Colton
11:00 am – Ground Floor,
Event Hall South
One-to-One Meetings
11:00 am – 2nd Floor
Spotlight Panel 1A
Beyond the Cure: The Brave New World of Revolutionary Cancer Therapeutics
Moderator:
-
Erkang Ai, Counsel, Global Regulatory, Hogan Lovells
Panel:
-
Gerald Commissiong, CBO, OS Therapies, Inc.
-
Gadareth Higgs, Business Development Lead, Circurna
-
Richard Kornbluth, President & CSO, Multimeric Biotherapeutics, Inc.
-
Julie O’Shaughnessy, COO, Vivodyne
-
Daniel Teper, CEO, Naya Therapeutics
11:00 am – 12th Floor
Spotlight Panel 1B
Rewiring Minds: Breakthroughs in Brain & CNS Health
Moderator:
-
Ginger Johnson, SVP, Lumanity
Panel:
-
Connor Glass, CEO & Founder, Phantom Neuro
-
Beth Hoffman, CEO, Origami Therapeutics, Inc.
-
Adam Rogers, CEO, NervGen Pharma
-
Arun Swaminathan, CEO, Coya Therapeutics, Inc.
-
Brent Vaughan, CEO & Founder, Eratos Therapeutics
12:00 pm – Ground Floor,
Event Hall South
Lunch
1:00 pm – 2nd Floor
Dialogue 1A
Rare Disease Therapies: Challenges in Development and Regulatory Pathways
Moderator:
-
Chris Vlahos, VP, External Innovation, Acadia Pharmaceuticals
Panel:
-
Shelley Hartman, CEO, Aegle Therapeutics Corporation
-
Jennifer Schranz, SVP, Global Head, Rare Diseases, Ipsen
-
Melindah Sharma, Managing Director, Commercialization, Supply Chain & Venture Capital, Manatt Health
-
Rachel Sher, Life Sciences & FDA Partner, Manatt Health
2:00 pm – Ground Floor,
Event Hall South
One-to-One Meetings
2:00 pm – 2nd Floor
Spotlight Panel 2A
Where Code Meets Cells: Forging the TechBio Future
Moderator:
-
Sebastien Latapie, Partner, Avant Bio
Panel:
-
Bigyan Bista, SVP & Head of Business Development, Enveda
-
Dan Que Pham, Co-Founder & COO, Oncodea
-
Irene Rombel, CEO, President & Co-Founder, BioCurie
-
Ignacio Willats, Co-Founder & CCO, Mytos
3:10 pm – 2nd Floor
Spotlight Panel 3A
Immunity Unleashed: Next-Gen Therapies & Immune Engineering
Moderator:
-
Melindah Sharma, Managing Director, Commercialization, Supply Chain & Venture Capital, Manatt Health
Panel:
-
Robert Arch, President, Immunophotonics, Inc.
-
Frank Bedu-Addo, President & CEO, PDS Biotechnology Corporation
-
Michael Montgomery, CMO & Co-Founder, Tidewave Bio
-
Wenzhi Tian, CEO, ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
-
Ming-Ru Wu, Co-Founder, TroGen Therapeutics
3:10 pm – 12th Floor
Spotlight Panel 3B
Healthspan Horizons: Advancing Longevity Therapeutics
Moderator:
-
Komal Bajaj, Chief Quality Officer, NYC Health + Hospital (Jacobi/NCB)
Panel:
-
Thomas Ichim, President & CSO, Immorta Bio
-
Marc Jones, CEO, Altoida, Inc.
-
Hans Keirstead, Chairman, Immunis, Inc.
-
Shreefāl Mehta, Co-Founder & CBO, Repoxegen Therapeutics Inc.
4:15 pm – 2nd Floor
End of Day “Big Think" Plenary Session
The Great Biopharma Reset: Will Today’s Challenging Environment Result in a more Resilient Sector?
Moderator:
-
Dennis Purcell, Founder & Senior Advisor, Aisling Capital
Panel:
-
Jo Natauri, Founder & Managing Partner, Invidia Capital Management
-
Umer Raffat, Equity Research, Evercore ISI
-
Philip Ross, Vice Chairman, Global Healthcare Investment Banking, Jefferies LLC
-
Eric Schmidt, Biotechnology Analyst, Cantor Fitzgerald